ALPHA TRIBE

Infinium Pharmachem LimitedUpdates, 16-01-2026: Press Release

16-01-2026 | 11:48 am

Infinium Pharmachem has commissioned its new contrast media raw materials facility, a key forward integration. This move targets ₹100 Cr annual revenue within 3 years at ~30% EBITDA margin, expected to boost blended EBITDA to ~20%.

No comments yet. Be the first to comment!

All announcements from Infinium Pharmachem Limited